MAOB and Alzheimer disease: We also demonstrated similar properties for 3H-BU99008 using competition studies, where binding of BU99008 to HA binding sites in both CN and AD cases was not affected by the increasing concentrations of MAO B inhibitors deprenyl and safinamide.